首页 | 本学科首页   官方微博 | 高级检索  
检索        

PD-L1阻断对慢性髓系白血病源性树突状细胞的功能影响
引用本文:王春燕,张连生,田发青,黄睿.PD-L1阻断对慢性髓系白血病源性树突状细胞的功能影响[J].中国实验血液学杂志,2008,16(5):1146-1149.
作者姓名:王春燕  张连生  田发青  黄睿
作者单位:1. 兰州大学第二医院血液肿瘤科,甘肃兰州,730030
2. 江苏江都市人民医院血液肿瘤科,江苏省江都市,江都,225200
3. 北京大学医学部,北京,100083
摘    要:程序性死亡-1配体-1(PD-L1)作为近年来发现的B7家族新的成员,已被证实有免疫负调节作用,白血病源性树突状细胞(DC)高表达PD-L1可能是影响其功能的原因之一,本研究试图阻断PD-L1在DC上的表达以增强白血病源性DC的免疫刺激功能。应用人rhGM-CSF、rhIL-4及TNF-α细胞因子组合诱导慢性髓系白血病细胞(CML)分化DC,观察给予加或不加PD-L1单克隆抗体对DC的影响。应用流式细胞术检测DC免疫表型及PD-L1,MTT法检测DC刺激自体T淋巴细胞的增殖能力,ELISA法测定上清液中IFN-γ、IL-2和IL-10的水平。结果显示,负性调节分子PD-L1随着慢性髓系白血病源性树突状细胞(CML-DC)成熟表达不断升高,阻断PD-L1能增强CML-DC刺激自体T淋巴细胞增殖的能力,促进T细胞分泌IFN-γ和IL-2并抑制IL-10的产生(p<0.05)。结论:阻断PD-L1可增强白血病源性DC的功能,为白血病DC瘤苗治疗技术提供了新的方法。

关 键 词:树突状细胞  PD-L1  慢性髓系性白血病

Effect of PD-L1 Blockade on Function of Dendritic Cells Derived from Chronic Myelocytic Leukemia
WANG Chun-Yan,ZHANG Lian-Sheng,TIAN Fa-Qing,HUANG Rui.Effect of PD-L1 Blockade on Function of Dendritic Cells Derived from Chronic Myelocytic Leukemia[J].Journal of Experimental Hematology,2008,16(5):1146-1149.
Authors:WANG Chun-Yan  ZHANG Lian-Sheng  TIAN Fa-Qing  HUANG Rui
Institution:Department of Hematology and Oncology, The Second Hospital, Lanzhou University, Lanzhou, 730030, Gansu Province, China.
Abstract:Programmed death-1 ligand-1(PD-L1) is a recently identified member of the B7 family molecules and is shown to mediate the inhibition of immune responses. This study was purposed to enhance the weak immunological function of dendritic cells (DCs) derived from the patients with chronic myelocytic leukemia (CML) by blockade of the expression of PD-L1. Bone marrow mononuclear cells (BMMNCs) of CML patients were induced into DCs in the presence of cytokine cocktail of rhGM-CSF, rhIL-4 and TNF-alpha. The phenotypes of DCs were detected by flow cytometry, mixed lymphocyte reaction was analyzed by MTT assay and IFN-gamma, IL-2 and IL-10 in the cell culture supernant were detected by ELISA. The results showed that the expression of PD-L1 on CML-DCs was upregulated with the maturation of CML-DCs. PD-L1-blockaded DCs could enhance T lymphocyte proliferation, increase the secretion of IL-2 and IFN-gamma, and inhibit the production of IL-10. Taken together, PD-L1-blockaded DCs originated from CML cells had more potent immunostimulatory capability. It is concluded that PD-L1 blockaded can enhance the function of CML-DCs. This approach presents new possibilities for achieving anti-tumor immunity by DC-based vaccination.
Keywords:dendritic cell  programmed death-1 ligand-1  chronic myelocytic leukemia
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号